Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEFORE Study: Efficacy of Refigura in Obesity
NCT03557424Phase 4Completed
- Sponsor
- Heilpflanzenwohl AG
- Start
- Apr 2017
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (3 arms), sponsored by Heilpflanzenwohl AG. Primary endpoint: Changes in Bodyweight at 8 weeks. Started Apr 2017; status: completed.
Beyond the preview
Go deeper on NCT03557424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557424.